Target Name: INO80C
NCBI ID: G125476
Review Report on INO80C Target / Biomarker Content of Review Report on INO80C Target / Biomarker
INO80C
Other Name(s): INO80C variant 1 | C18orf37 | hIes6 | IES6 homolog | IN80C_HUMAN | INO80 complex subunit C (isoform 1) | IES6 | INO80 complex subunit C, transcript variant 1 | INO80 complex subunit C

Understanding INO80C: A Potential Drug Target and Biomarker

INO80C (INO80C variant 1) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the IMP family, which includes proteins that play a critical role in the development and maintenance of tissues. INO80C is known for its unique structure and its ability to interact with various signaling pathways.

Recent studies have suggested that INO80C may have potential as a drug target or biomarker. This is because of its unique structure and the various functions that it is known to play in the body.

Structure and Functions

INO80C is a transmembrane protein that is composed of four domains: an N-terminus, a T-terminus, a middle domain, and an C-terminus. The N-terminus is responsible for the protein's ability to interact with various signaling pathways, while the T-terminus is responsible for its ability to interact with the cell surface. The middle domain is responsible for the protein's unique structure and its ability to interact with the cytoskeleton. The C-terminus is responsible for the protein's ability to interact with various signaling pathways and for its role in the development and maintenance of tissues.

One of the most interesting features of INO80C is its ability to interact with various signaling pathways. This is because of its unique structure, which allows it to interact with different signaling pathways in a variety of ways. For example, INO80C has been shown to interact with the PI3K/AKT signaling pathway, the NF-kappa-B signaling pathway, and the TGF-β signaling pathway.

In addition to its ability to interact with various signaling pathways, INO80C is also known for its role in the development and maintenance of tissues. This is because of its unique structure, which allows it to interact with different signaling pathways in a variety of ways. For example, INO80C has been shown to play a role in the development and maintenance of the nervous system, the cardiovascular system, and the kidneys.

Drug Target Potential

The unique structure of INO80C and its ability to interact with various signaling pathways make it an attractive drug target. This is because of its potential to modulate the activity of various signaling pathways and to contribute to the development and maintenance of tissues.

One potential way to target INO80C is through the use of small molecules that can modulate its activity. For example, small molecules that can inhibit the activity of INO80C's signaling domains or that can modulate its stability in the cell could be developed as potential drugs.

Another potential way to target INO80C is through the use of antibodies that can recognize and interact with it. This is because INO80C is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys, so antibodies that can recognize and interact with it could be developed as potential drugs.

Biomarker Potential

INO80C is also an attractive biomarker for a variety of diseases. This is because of its unique structure and its ability to interact with various signaling pathways. For example, INO80C has been shown to be involved in the development and maintenance of certain diseases, such as cancer and neurodegenerative diseases.

Conclusion

INO80C is a protein that is expressed in various tissues of the body and is known for its unique structure and its ability to interact with various signaling pathways. Recent studies have suggested that INO80C may have potential as a drug target or biomarker. This is because of its unique structure and the various functions that it is known to play in the body. Further research is needed to fully understand the potential of INO80C as a drug target or biomarker.

Protein Name: INO80 Complex Subunit C

Functions: Proposed core component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair

The "INO80C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about INO80C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

INO80D | INO80E | Inositol 1,4,5-Trisphosphate Receptor (InsP3R) | Inositol hexakisphosphate kinase | Inositol Monophosphatase | INPP1 | INPP4A | INPP4B | INPP5A | INPP5B | INPP5D | INPP5E | INPP5F | INPP5J | INPP5K | INPPL1 | INS | INS-IGF2 | INSC | INSIG1 | INSIG2 | INSL3 | INSL4 | INSL5 | INSL6 | INSM1 | INSM2 | INSR | INSRR | Insulin-like growth factor | Insulin-like growth factor 2 mRNA binding protein | Insulin-like growth factor 2 mRNA-binding protein 1 (isoform 2) | Insulin-like growth factor-binding protein | INSYN1 | INSYN2A | INSYN2B | Integrator complex | Integrin alpha1beta1 (VLA-1) receptor | Integrin alpha2beta1 (VLA-2) receptor | Integrin alpha2beta3 Receptor | Integrin alpha3beta1 receptor | Integrin alpha4beta1 (VLA-4) receptor | Integrin alpha4beta7 (LPAM-1) receptor | Integrin alpha5beta1 (VLA-5) receptor | Integrin alpha5beta3 receptor | Integrin alpha6beta1 Receptor | Integrin alpha6beta4 receptor | Integrin alpha7beta1 Receptor | Integrin alpha9beta1 receptor | Integrin alphaEbeta7 receptor | Integrin alphaLbeta2 (LFA-1) receptor | Integrin alphaMbeta2 (MAC-1) Receptor | Integrin alphavbeta1 | Integrin alphavbeta3 (vitronectin) receptor | Integrin alphavbeta5 receptor | Integrin alphavbeta6 receptor | Integrin alphavbeta8 Receptor | Integrin Receptor | Integrin-linked kinase | Interferon | Interferon-alpha (IFN-alpha) | Interferon-gamma Receptor | Interleukin 17 | Interleukin 21 receptor complex | Interleukin 23 complex (IL-23) | Interleukin 35 | Interleukin-1 | Interleukin-1 receptor-associated kinase (IRAK) | Interleukin-12 (IL-12) | Interleukin-18 Receptor Complex | Interleukin-27 (IL-27) Complex | Interleukin-39 (IL-39) | Interleukin-7 receptor | Intraflagellar transport complex | Intraflagellar transport complex A | Intraflagellar transport complex B | Intrinsic Tenase Complex | INTS1 | INTS10 | INTS11 | INTS12 | INTS13 | INTS14 | INTS15 | INTS2 | INTS3 | INTS4 | INTS4P1 | INTS4P2 | INTS5 | INTS6 | INTS6L | INTS6L-AS1 | INTS6P1 | INTS7 | INTS8 | INTS9 | INTU | Invariant T Cell Receptor | INVS